PubMed

Telomerase structure paves the way for new cancer therapies.

Skordalakes E.

Future Oncol. 2009 Mar;5(2):163-7. Review.PMID: 19284375 [PubMed - indexed for MEDLINE]Related articles

Telomerase and the benefits of healthy living.

Skordalakes E.

Lancet Oncol. 2008 Nov;9(11):1023-4. No abstract available. PMID: 19012852 [PubMed - indexed for MEDLINE]Related articles

Structure of the Tribolium castaneum telomerase catalytic subunit TERT.

Gillis AJ, Schuller AP, Skordalakes E.

Nature. 2008 Oct 2;455(7213):633-7. Epub 2008 Aug 31.PMID: 18758444 [PubMed - indexed for MEDLINE]Related articles

Function and structure of a prokaryotic formylglycine-generating enzyme.

Carlson BL, Ballister ER, Skordalakes E, King DS, Breidenbach MA, Gilmore SA, Berger JM, Bertozzi CR.

J Biol Chem. 2008 Jul 18;283(29):20117-25. Epub 2008 Apr 4.PMID: 18390551 [PubMed - indexed for MEDLINE]Related articlesFree article

Structure of the RNA-binding domain of telomerase: implications for RNA recognition and binding.

Rouda S, Skordalakes E.

Structure. 2007 Nov;15(11):1403-12.PMID: 17997966 [PubMed - indexed for MEDLINE]Related articles

Comparison of proteolytic susceptibility in phosphoglycerate kinases from yeast and E. coli: modulation of conformational ensembles without altering structure or stability.

Young TA, Skordalakes E, Marqusee S.

J Mol Biol. 2007 May 18;368(5):1438-47. Epub 2007 Mar 6.PMID: 17397866 [PubMed - indexed for MEDLINE]Related articles

Structural insights into RNA-dependent ring closure and ATPase activation by the Rho termination factor.

Skordalakes E, Berger JM.

Cell. 2006 Nov 3;127(3):553-64.PMID: 17081977 [PubMed - indexed for MEDLINE]Related articles

Structural mechanism of inhibition of the Rho transcription termination factor by the antibiotic bicyclomycin.

Skordalakes E, Brogan AP, Park BS, Kohn H, Berger JM.

Structure. 2005 Jan;13(1):99-109.PMID: 15642265 [PubMed - indexed for MEDLINE]Related articles

Structure and function of the conserved core of histone deposition protein Asf1.

Daganzo SM, Erzberger JP, Lam WM, Skordalakes E, Zhang R, Franco AA, Brill SJ, Adams PD, Berger JM, Kaufman PD.

Curr Biol. 2003 Dec 16;13(24):2148-58.PMID: 14680630 [PubMed - indexed for MEDLINE]Related articles

Structure of the Rho transcription terminator: mechanism of mRNA recognition and helicase loading.

Skordalakes E, Berger JM.

Cell. 2003 Jul 11;114(1):135-46.PMID: 12859904 [PubMed - indexed for MEDLINE]Related articles

A robust and scalable microfluidic metering method that allows protein crystal growth by free interface diffusion.

Hansen CL, Skordalakes E, Berger JM, Quake SR.

Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16531-6. Epub 2002 Dec 16.PMID: 12486223 [PubMed - indexed for MEDLINE]Related articlesFree article

Inhibition of human alpha-thrombin by a phosphonate tripeptide proceeds via a metastable pentacoordinated phosphorus intermediate.

Skordalakes E, Dodson GG, Green DS, Goodwin CA, Scully MF, Hudson HR, Kakkar VV, Deadman JJ.

J Mol Biol. 2001 Aug 17;311(3):549-55.PMID: 11493008 [PubMed - indexed for MEDLINE]Related articles

Bifunctional peptide boronate inhibitors of thrombin: crystallographic analysis of inhibition enhanced by linkage to an exosite 1 binding peptide.

Skordalakes E, Elgendy S, Goodwin CA, Green D, Scully MF, Kakkar VV, Freyssinet JM, Dodson G, Deadman JJ.

Biochemistry. 1998 Oct 13;37(41):14420-7.PMID: 9772168 [PubMed - indexed for MEDLINE]Related articles

Characterization of a class of peptide boronates with neutral P1 side chains as highly selective inhibitors of thrombin.

Deadman JJ, Elgendy S, Goodwin CA, Green D, Baban JA, Patel G, Skordalakes E, Chino N, Claeson G, Kakkar VV, et al.

J Med Chem. 1995 Apr 28;38(9):1511-22.PMID: 7739010 [PubMed - indexed for MEDLINE]Related articles